BERTELLI, CRISTINA
BERTELLI, CRISTINA
Universita' degli Studi di MILANO
Aberrant methylation of oncosuppressor genes detected in the peripheral blood of patients with chronic hepatitis C and hepatocellular carcinoma
2011 M. Sampietro, A.L. Fracanzani, D. Tavazzi, A. Cespiati, C. Bertelli, D. Bignamini, L.V.C. Valenti, S.R. Fargion
Are the determinants of steatosis Associated with chronic hepatitis C( CHC) different from those of non alcoholic fatty liver disease ( NAFLD? )
2006 E.A. Pulixi, A.L. Fracanzani, A. Maraschi, C. Bertelli, S.R. Fargion
Baseline alt and ferritin predict histological findings in NAFLD
2007 A.L. Fracanzani, L. Valenti, C. Bertelli, E. Fatta, E. Pulixi, S. Fargion
Baseline alt and ferritin predict histological findings in NAFLD
2007 A. L Fracanzani, L. Valenti, E. Fatta, C. Bertelli, E. Pulixi, S. Fargion
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma
2008 M. Sampietro, A.L. Fracanzani, L. Valenti, C. Bertelli, E. Fatta, D. Bignamini, D. Tavazzi, S. Fargion
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma
2008 M. Sampietro, A.L. Fracanzani, L. Valenti, C. Bertelli, E. Fatta, D. Bignamini, D. Tavazzi, S. Fargion
Contrast-enhanced ultrasonography (CEUS) and spiral computed tomography (CT) in the assessement of efficacy of percutaneous ablation treatments of hepatocellular carcinoma in cirrhosis
2008 A. L Fracanzani, A. Maraschi, L. Burdick, C. Bertelli, E. Fatta, N. Bonelli, D. Meregaglia, S. Fargion
Differential patterns of contrast-enhancement ultrasonography with SonoVue in small focal lesions arisng in cirrhosis
2006 C. Bertelli, A.L. Fracanzani, L. Burdick, A. Sangiovanni, N. Bonelli, M. Borio, A. Maraschi, G.P. Benedetti, S.R. Fargion
Echocardiographic epicardial fat thickness : preliminary results of a prospective study in non-alcoholic fatty liver disease
2010 R. Lombardi, T. Tonella, F. Massari, L.V.C. Valenti, C. Bertelli, L. Burdick, D. Bignamini, S.R. Fargion, A.L. Fracanzani
Echocardiographic epicardial fat thickness in non alcoholic fatty liver disease: a possible marker of metabolic syndrome and early vascular damage
2011 R. Lombardi, T. Tonella, F. Massari, L.V.C. Valenti, C. Bertelli, L. Burdick, D. Bignamini, E. Fatta, S.R. Fargion, A.L. Fracanzani
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease
2016 A.L. Fracanzani, G. Pisano, D. Consonni, S. Tiraboschi, A. Baragetti, C. Bertelli, G.D. Norata, P. Dongiovanni, L. Valenti, L. Grigore, T. Tonella, A. Catapano, S. Fargion
Evaluation of patients with NAFLD with or without increased ALT
2008 A.L. Fracanzani, L. Valenti, E. Bugianesi, G. Marchesini, M. Andreoletti, A. Colli, C. Bertelli, E. Fatta, S. Fargion
Ferro, steatosi e...
2009 E. Pulixi, D. Bignamini, E. Fatta, C. Bertelli, A.L. Fracanzani, L. Valenti, L. Devizzi, M. Maggioni, S. Fargion
Gallstone in nonalcoholic fatty liver disease : a possible risk factor for NASH
2010 C. Masetti, L.V.C. Valenti, G. Marchesini, L. Miele, A. Greco, M. Russello, A. Bellia, M. Porzio, C. Bertelli, S.R. Fargion, A.L. Fracanzani
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation : preliminary results
2020 G. Pisano, M.F. Donato, D. Consonni, G. Oberti, V. Borroni, R. Lombardi, F. Invernizzi, C. Bertelli, L. Caccamo, M. Porzio, D. Dondossola, G. Rossi, S. Fargion, A.L. Fracanzani
Hypermethylation of oncosuppressor genes in hereditary hemochromatosis
2010 M. Sampietro, A.L. Fracanzani, D. Tavazzi, C. Bertelli, R. Vaccaroli, R. Rametta, L.V.C. Valenti, S.R. Fargion
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease
2008 L. Valenti, L. Burdick, C. Bertelli, P. Dongiovanni, R. Rametta, E. Fatta, D. Bignamini, S. Fargion, A.L. Fracanzani
Insulin related early andothelial dysfuction in patients with non alcoholic fatty liver disease (NAFLD)
2006 L. Burdick, G. Santorelli, L. Valenti, A. Maraschi, A. Orsatti, C. Bertelli, A.L. Fracanzani, S.R. Fargion
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown
2022 F. Cinque, A. Cespiati, R. Lombardi, A. Costantino, G. Maffi, F. Alletto, L. Colavolpe, P. Francione, G. Oberti, E. Fatta, C. Bertelli, G. Sigon, P. Dongiovanni, M. Vecchi, S. Fargion, A.L. Fracanzani
Natural history of de-novo portal vein thrombosis in patients with hepatocellular carcinoma
2010 A. Sangiovanni, A.L. Fracanzani, L. Burdick, L.V. Forzenigo, S. Vavassori, C. Bertelli, D. Bignamini, M. Iavarone, S.R. Fargion, M. Colombo